Table 2.

Demographic Features of Control Subjects and Patients with DE

Group	n	Mean Age ± SD (y)	% Female
Control	17	45.1 ± 14.7	70
All DE	35	57.5 ± 13.2	86.1
MGD	20	55.3 ± 16.4	89
SS	9	58.7 ± 18.3	100
NK	6*	61.6 ± 6.0	67

^*Diabetic neuropathy, n = 2; ophthalmic zoster, n = 2; scleral buckling procedure, n = 1; surgical trigeminal ganglion ablation, n = 1.